Our core business is to discover and commercialize innovative products in eye care with proven clinical evidence to create new solutions. Our focus lies on corneal cross-linking, the non-invasive correction of ecstatic corneal disorders and the new method for the treatment of infectious keratitis, bullous keratopathy and Fuch’s dystrophy. In partnership with our distribution partners we provide physicians around the world the possibility to maintain and improve eye health care for their patients.